Virology Flashcards
HPV (oncogenesis)
Localized infection - skin warts
Oncogenic: via E6 disabling host Rb and E7 acting on host’s p53
*can cause squamous cell carcinoma of cervix
Lysogenic (Temperate) Virus
Lysogenic cycle - host cell multiplies and daughter cells contain the prophage
Lytic (Virulent) Virus
Kills host immediately; particles released by host cell lysis or budding
EBV (oncogenesis and evasion mechanism)
Receptor: CR2
Cell: B cell
Evasion: produces IL-10 (anti-inflamm. cytokine)
*silent sub-clinical virus
HIV (tropism)
Receptor: CD4 (plus CCR5 and CXR4 on macrophage)
Cell: Th and Macrophages
Influenza A (tropism)
Receptor: Sialic acid (Neuraminidase on virus breaks down sialic acid in order for aggregated virions to bud out of the cell)
Cell: epithelial cell
Rabies (tropism and inclusions)
Receptor: nicotenic ACh Cell: neurons Inclusions: Negri bodies Mechanism: retrograde, affects CNS eventually "slow virus"
Viral Attachment Proteins (VAP)
Viral glycoproteins located on the outer leaflet (envelope for enveloped viruses OR the capsid for naked viruses)
*contributes to the viral “tropism”
RNA Dependent RNA-Pol (RNA Replicase)
Group IV codes for RR, Group III and V code for RR and also contains the enzyme in their virion
Antigenic Drift
Small change in a genome w/in specific strain, happens at slow rate compared to Ag Shift
*type of antigenic variation (e.g. - orthomyxo specifically influenza virus)
Antigenic Shift
Mix and match of chromosomes btwn 2 diff strains of virus - faster change than drift
*reassortment of genome (type of antigenic variation)
Phenotypic Mix
Genome of 1 virus is coated w/ proteins from another viral genome mixed w/ capsid from another virus
Viremia
Transmission of virus by blood throughout the entire body reaching distant organs
Paralytic Poliomyelitis
Fecal-oral path w/ initial propagation in SI followed by viral reach to mesenteric lymph nodes
- initial viremia bloodstream brings virus to some organs
- secondary viremia brings virus to CNS
- IgG produced
Incubation Period
Pt is asymptomatic (virus enters host cell and is not detectable)
Prodromal Period
Non-specific sx’s present
Specific-illness Period
Specific sx’s signature of certain viral dz
Recovery Period
Healing of dz, or can move into chronic state or cause infection at a secondary site
Congenital Rubella
ROS: cataracts, patent ductus arteriosus (PDA), intellectual disability, microcephaly, deafness
*transplacental transmission
Cytomegalovirus (CMV)
Inclusions: “owl’s eye” in nucleus
Evasion: blocks MHC-I being presented
*can be transmitted trans-placental or breastfeeding
(Most common viral cause of death in BMT pt’s)
Virus eradicated by vaccine?
Smallpox
Type I Hypersensitivity
Mediator: IgE and vasoactive mediators (mast cell degranulation)
Benefits: anti-parasitic responses and toxin neutralization
Pathologic effects: localized allergies, systemic anaphylaxis
Microbes involved in Pulmonary Type I Hypersensitivity
Molds: leads to asthma
G-ve: leads to organic dust toxic syndrome or Asthma
Type II Hypersensitivity
Mediator: IgG w/ Ag
Mechanism: complement mediated cytotoxicity, or modification of cell surface receptor function
Benefit: lysis/phagocytosis of extracellular microbes
Pathologic effect: RBC destruction, tissue damage
Examples of Type II Hypersensitivities
Infectious cause: Guillan-Barre, Dengue and Zika, CMV (HHV-5)
Ag mimicry: acute RF following strep throat infection, RBC lysis due to ABO incompatibility
Drug induced: penicillin allergy
Type III Hypersensitivity
Mediator: IgG w/ soluble Ag (immune complex)
Mechanism: complement activation
Benefit: acute inflamm @ site of extracellular microbes
Pathologic effect: Arthus rxn, serum sickness and generalized drug rxn’s
Infectious cause of Type III Hypersensitivity
Staph infective endocarditis, strep glomerulonephritis, Arthus Rxn, Serum Sickness-like post-infectious Rxn (viral infections)
*SLE and RA